temozolomide has been researched along with Hepatitis B in 6 studies
Hepatitis B: INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this study is to clarify the clinical features of temozolomide (TMZ)-related hepatitis B virus (HBV) reactivation and to identify HBV reactivation predictive factors." | 8.02 | Hepatitis B virus reactivation during temozolomide administration for malignant glioma. ( Chonan, M; Inoue, J; Kanamori, M; Masamune, A; Osada, Y; Saito, R; Shimoda, Y; Shoji, T; Tominaga, T; Uenohara, H, 2021) |
| "A 61-year-old man with glioblastoma and positive for hepatitis B surface antigen (HBsAg) developed acute hepatitis due to hepatitis B virus (HBV) reactivation after concomitant postoperative treatment with temozolomide (75 mg/m(2)/day) and radiation therapy (60 Gy in 30 fractions)." | 7.77 | Reactivation of hepatitis B virus after glioblastoma treatment with temozolomide--case report. ( Kayama, T; Miyakita, Y; Narita, Y; Ohno, M; Shibui, S; Ueno, H, 2011) |
| "The tumor was partially resected and anaplastic astrocytoma was diagnosed." | 5.38 | Hepatitis B virus reactivation associated with temozolomide for malignant glioma: a case report and recommendation for prophylaxis. ( Fujimoto, Y; Hashimoto, N; Kagawa, N; Kinoshita, M; Miyazaki, Y; Takehara, T; Tanaka, S; Yakushijin, T; Yoshimine, T, 2012) |
| "The purpose of this study is to clarify the clinical features of temozolomide (TMZ)-related hepatitis B virus (HBV) reactivation and to identify HBV reactivation predictive factors." | 4.02 | Hepatitis B virus reactivation during temozolomide administration for malignant glioma. ( Chonan, M; Inoue, J; Kanamori, M; Masamune, A; Osada, Y; Saito, R; Shimoda, Y; Shoji, T; Tominaga, T; Uenohara, H, 2021) |
| " Temozolomide (TMZ) is an alkylating agent used for the treatment of glioblastoma multiforme (GBM), the most common and deadliest of malignant primary brain tumors." | 3.80 | Glioblastoma multiforme and hepatitis B: do the right thing(s). ( Begini, P; Delle Fave, G; Gallina, S; Marignani, M; Minniti, G; Purchiaroni, F, 2014) |
| "A 61-year-old man with glioblastoma and positive for hepatitis B surface antigen (HBsAg) developed acute hepatitis due to hepatitis B virus (HBV) reactivation after concomitant postoperative treatment with temozolomide (75 mg/m(2)/day) and radiation therapy (60 Gy in 30 fractions)." | 3.77 | Reactivation of hepatitis B virus after glioblastoma treatment with temozolomide--case report. ( Kayama, T; Miyakita, Y; Narita, Y; Ohno, M; Shibui, S; Ueno, H, 2011) |
| "The tumor was partially resected and anaplastic astrocytoma was diagnosed." | 1.38 | Hepatitis B virus reactivation associated with temozolomide for malignant glioma: a case report and recommendation for prophylaxis. ( Fujimoto, Y; Hashimoto, N; Kagawa, N; Kinoshita, M; Miyazaki, Y; Takehara, T; Tanaka, S; Yakushijin, T; Yoshimine, T, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Shoji, T | 1 |
| Kanamori, M | 1 |
| Inoue, J | 1 |
| Saito, R | 1 |
| Osada, Y | 1 |
| Shimoda, Y | 1 |
| Chonan, M | 1 |
| Uenohara, H | 1 |
| Masamune, A | 1 |
| Tominaga, T | 1 |
| Purchiaroni, F | 1 |
| Begini, P | 1 |
| Minniti, G | 1 |
| Gallina, S | 1 |
| Delle Fave, G | 1 |
| Marignani, M | 1 |
| Fujimoto, Y | 1 |
| Hashimoto, N | 1 |
| Kinoshita, M | 1 |
| Miyazaki, Y | 1 |
| Tanaka, S | 1 |
| Yakushijin, T | 1 |
| Takehara, T | 1 |
| Kagawa, N | 1 |
| Yoshimine, T | 1 |
| Ohno, M | 1 |
| Narita, Y | 1 |
| Miyakita, Y | 1 |
| Ueno, H | 1 |
| Kayama, T | 1 |
| Shibui, S | 1 |
| Chheda, MG | 1 |
| Drappatz, J | 1 |
| Greenberger, NJ | 1 |
| Kesari, S | 1 |
| Weiss, SE | 1 |
| Gigas, DC | 1 |
| Doherty, LM | 1 |
| Wen, PY | 1 |
| Grewal, J | 1 |
| Dellinger, CA | 1 |
| Yung, WK | 1 |
6 other studies available for temozolomide and Hepatitis B
| Article | Year |
|---|---|
Hepatitis B virus reactivation during temozolomide administration for malignant glioma.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; DNA, Viral; Glioma; Hepatitis B; Hepatitis B Ant | 2021 |
Glioblastoma multiforme and hepatitis B: do the right thing(s).
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Glioblastoma; Hepatitis B; Hepatiti | 2014 |
Hepatitis B virus reactivation associated with temozolomide for malignant glioma: a case report and recommendation for prophylaxis.
Topics: Antineoplastic Agents, Alkylating; Antiviral Agents; Astrocytoma; Brain Neoplasms; Carrier State; Ch | 2012 |
Reactivation of hepatitis B virus after glioblastoma treatment with temozolomide--case report.
Topics: Acute Disease; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Fatal Outcome; Gliob | 2011 |
Hepatitis B reactivation during glioblastoma treatment with temozolomide: a cautionary note.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; DNA, Viral; Glioblastoma; Hepatitis | 2007 |
Fatal reactivation of hepatitis B with temozolomide.
Topics: Aged; Anticonvulsants; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Fatal Outcom | 2007 |